Furthermore, an increased HO-1 expression level has been reported in different cancers, including brain tumors, chronic myeloid leukemia, melanoma and lymphosarcoma, suggesting a possible contribution of HO-1 to tumorigenesis [7–9]. Here, HMOX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.